Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO‐incompatible red blood cell transfusion

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|3|605-610

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.3, 2015-03, pp. : 605-610

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eculizumab inhibits hemolysis in a model of ABO‐incompatible red blood cell transfusion

By  

TRANSFUSION, Vol. 55, Iss. 7, 2015-07 ,pp. : 1823-1824

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transfusion Support for ABO-Incompatible Progenitor Cell Transplantation

By  

Transfusion Medicine and Hemotherapy, Vol. 43, Iss. 1, 2016-0 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

Acute Intravascular Hemolysis due to ABO-Incompatible Platelet Transfusion

By  

Acta Haematologica, Vol. 110, Iss. 4, 2003-12 ,pp. : 211-212

Karger

Access to resources Recommend Favorite

Who's afraid of incompatible plasma? A balanced approach to the safe transfusion of blood products containing ABO‐incompatible plasma

By  

TRANSFUSION, Vol. 58, Iss. 2, 2018-02 ,pp. : 532-538

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atypical hemolytic uremic syndrome diagnosed four years after ABO‐incompatible kidney transplantation

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 61-65

John Wiley & Sons Inc

Access to resources Recommend Favorite